Shinva Medical InstrumentLtd Beheer

Beheer criteriumcontroles 3/4

De CEO Shinva Medical InstrumentLtd is Baoxian Gong, benoemd in Feb2022, heeft een ambtstermijn van 2.75 jaar. bezit rechtstreeks 0.009% van de aandelen van het bedrijf, ter waarde CN¥ 951.98K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3 jaar en 3.8 jaar.

Belangrijke informatie

Baoxian Gong

Algemeen directeur

CN¥2.3m

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	2.8yrs
Eigendom CEO	0.009%
Management gemiddelde ambtstermijn	3yrs
Gemiddelde ambtstermijn bestuur	3.8yrs

Recente managementupdates

Recent updates

Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Jul 18

Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Jun 07

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Apr 22

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Mar 28

CEO

Baoxian Gong (48 yo)

2.8yrs

Tenure

CN¥2,312,900

Compensatie

Mr. Baoxian Gong is General Manager of Shinva Medical Instrument Co., Ltd., since February 23, 2022.

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Baoxian Gong	General Manager	2.8yrs	CN¥2.31m	0.0086% CN¥ 952.0k
Juanjuan Zhou	CFO & Director	3.3yrs	CN¥942.70k	0.020% CN¥ 2.3m
Cai Xiang Li	Deputy GM & Secretary of the Board	7.3yrs	CN¥978.80k	0.036% CN¥ 3.9m
Jing Qu	Deputy General Manager	4.6yrs	CN¥1.57m	0.022% CN¥ 2.4m
Jiaqiang Wang	Deputy General Manager	2.3yrs	CN¥1.23m	0.0096% CN¥ 1.1m
Qingguo Zhu	Deputy General Manager	2.3yrs	CN¥1.64m	0.011% CN¥ 1.2m

3.0yrs

Gemiddelde duur

47yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 600587 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Juanjuan Zhou	CFO & Director	3.3yrs	CN¥942.70k	0.020% CN¥ 2.3m
Ailing Pan	Independent Director	4.3yrs	CN¥80.00k	geen gegevens
Yu Quan Wang	Chairman	4.5yrs	CN¥1.25m	0.035% CN¥ 3.9m
Weijun Gu	Independent Director	4.4yrs	CN¥80.00k	0.0011% CN¥ 118.9k
Hongtao Cui	Employee Representative Director	7.6yrs	CN¥2.60m	0.023% CN¥ 2.6m
Xiao Li Zhao	Director	7.6yrs	CN¥1.03m	geen gegevens
Yueyong Wang	Director	3.8yrs	CN¥33.30k	geen gegevens
Xiao Li Li	Director	3.8yrs	CN¥94.00k	geen gegevens
Li Yong Jiang	Independent Director	3.8yrs	CN¥80.00k	geen gegevens
Lehai Mou	Chairman of the Supervisory Board	3.8yrs	geen gegevens	geen gegevens
Yuan Li	Independent Director	3.3yrs	CN¥80.00k	geen gegevens
Fuquan Zhang	Director	1.3yrs	CN¥33.30k	geen gegevens

3.8yrs

Gemiddelde duur

56.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 600587 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).

Shinva Medical InstrumentLtd Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Shinva Medical Instrument Co.,Ltd., Annual General Meeting, Apr 18, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.22 (vs CN¥0.20 in 3Q 2023)

Now 23% undervalued

Estimating The Fair Value Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587)

Shinva Medical Instrument Co.,Ltd. to Report Q3, 2024 Results on Oct 30, 2024

Investor sentiment improves as stock rises 20%

Returns At Shinva Medical InstrumentLtd (SHSE:600587) Are On The Way Up

Second quarter 2024 earnings released: EPS: CN¥0.74 (vs CN¥0.43 in 2Q 2023)

Is Shinva Medical InstrumentLtd (SHSE:600587) Using Too Much Debt?

Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Business And Shares Still Trailing The Market

Now 19% overvalued

Shinva Medical Instrument Co.,Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Now 22% overvalued

Does This Valuation Of Shinva Medical Instrument Co.,Ltd. (SHSE:600587) Imply Investors Are Overpaying?

Investor sentiment deteriorates as stock falls 17%

Dividend increased to CN¥0.50

First quarter 2024 earnings released: EPS: CN¥0.45 (vs CN¥0.46 in 1Q 2023)

Does Shinva Medical InstrumentLtd (SHSE:600587) Have A Healthy Balance Sheet?

Full year 2023 earnings: EPS and revenues miss analyst expectations

Shinva Medical Instrument Co.,Ltd., Annual General Meeting, Apr 18, 2024

Shinva Medical InstrumentLtd's (SHSE:600587) Returns On Capital Not Reflecting Well On The Business

Investor sentiment deteriorates as stock falls 19%

Shinva Medical Instrument Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 29, 2024

Third quarter 2023 earnings released: EPS: CN¥0.26 (vs CN¥0.24 in 3Q 2022)

Shinva Medical Instrument Co.,Ltd. to Report Q3, 2023 Results on Oct 25, 2023

Second quarter 2023 earnings released: EPS: CN¥0.57 (vs CN¥0.48 in 2Q 2022)

New minor risk - Dividend sustainability

Full year 2022 earnings released: EPS: CN¥1.23 (vs CN¥1.37 in FY 2021)

Investor sentiment improves as stock rises 17%

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.24 (vs CN¥0.27 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.48 (vs CN¥0.45 in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target increased to CN¥41.65

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.27 (vs CN¥0.20 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.45 (vs CN¥0.25 in 2Q 2020)

Investor sentiment improved over the past week

Zou Huiling acquired 16.67% stake in Beijing Huaco Healthcare Technologies Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 25 million.

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.36 (vs CN¥0.08 in 1Q 2020)

New 90-day low: CN¥12.23

New 90-day low: CN¥13.25

New 90-day low: CN¥14.41

New 90-day low: CN¥14.78

New 90-day low: CN¥15.88

Third quarter earnings released

Shinva Medical Instrument Co., Ltd. to Report Q3, 2020 Results on Oct 31, 2020

First half earnings released

Nanyang Great Health Medical Care Industry Development Co., Ltd acquired 80% stake in Nanyang Orthopedics High-tech Zone Hospital Co., Ltd. from Shinva Medical Instrument Co., Ltd. (SHSE:600587) for CNY 53.8 million.

New 90-day high - CN¥18.41

Shinva Medical Instrument Co., Ltd. to Report First Half, 2020 Results on Aug 29, 2020

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd